SlideShare a Scribd company logo
Pitfalls During HospitalPitfalls During Hospital
Discharges:Discharges:
Focus on CardiologyFocus on Cardiology
Presented by:Presented by:
Carolyn StrimikeCarolyn Strimike
Cardiology Nurse PractitionerCardiology Nurse Practitioner
Components of HospitalComponents of Hospital
Discharge InstructionsDischarge Instructions::
 Activity restrictions/guidelinesActivity restrictions/guidelines
 Risk Factor ModificationRisk Factor Modification
 Dietary restrictionsDietary restrictions
 Home care/monitoring (dressings, BP, bloodHome care/monitoring (dressings, BP, blood
sugar, weights)sugar, weights)
 Physician Follow-up (routine, problems –Physician Follow-up (routine, problems –
who and when to contact)who and when to contact)
 Follow-up testingFollow-up testing
 Medications (existing and new)Medications (existing and new)
How much time do you thinkHow much time do you think
a Physician should spenda Physician should spend
providing Dischargeproviding Discharge
Instructions?Instructions?
What is Average AmountWhat is Average Amount
of Time MD spendsof Time MD spends
on Dischargeon Discharge
Instructions?Instructions?
Most Common QuestionMost Common Question
Patients Ask UponPatients Ask Upon
Discharge?Discharge?
“When can I
Leave?”
Rates of CMS Rehospitalization WithinRates of CMS Rehospitalization Within
30 Days after Hospital Discharge30 Days after Hospital Discharge
Jencks SF et al.Jencks SF et al. N Engl J MedN Engl J Med 2009;360:1418-14282009;360:1418-1428
ED Visits Post DischargeED Visits Post Discharge
 2.3 million visits from patients2.3 million visits from patients
discharged from hospital within 7 daysdischarged from hospital within 7 days
 Uninsured 3 times more likely to visitUninsured 3 times more likely to visit
EDED
1/3 chronically ill adults do not use1/3 chronically ill adults do not use
medications due to cost and do not tellmedications due to cost and do not tell
cliniciansclinicians
Arch Int Med 2004 (164) 1749-55Arch Int Med 2004 (164) 1749-55
MedicationMedication
Noncompliance orNoncompliance or
Mistakes Account forMistakes Account for
24% of Readmission Rate24% of Readmission Rate
 Multidrugs/ multinames: “You meanMultidrugs/ multinames: “You mean WarfarinWarfarin andand
CoumadinCoumadin are the same drug?”are the same drug?”
 Use both generic and brands whenever possibleUse both generic and brands whenever possible
when teaching ptswhen teaching pts
 Discharge medication lists need to be explicitDischarge medication lists need to be explicit
 Check on patient’s system for taking medicationsCheck on patient’s system for taking medications
 Seven day/ 4 compartment per day pill boxes are helpfulSeven day/ 4 compartment per day pill boxes are helpful
 A home visit or f/u phone call is VERY helpfulA home visit or f/u phone call is VERY helpful
 70% Patients Use Alternative Therapy70% Patients Use Alternative Therapy
 50 to 70% patients do NOT report50 to 70% patients do NOT report
herbal medication usage – MUST ASKherbal medication usage – MUST ASK
PATIENTSPATIENTS
 AntiplateletsAntiplatelets
 Beta-BlockersBeta-Blockers
 ACEI/ARBsACEI/ARBs
 StatinsStatins
 CoumadinCoumadin
Acute MI Quality MeasuresAcute MI Quality Measures
1) Aspirin at arrival1) Aspirin at arrival
2)2) Aspirin at dischargeAspirin at discharge
3)3) ACE inhibitor or ARB for LV systolicACE inhibitor or ARB for LV systolic
dysfunctiondysfunction
4) Beta-blockers at arrival4) Beta-blockers at arrival
5)5) Beta-blockers at dischargeBeta-blockers at discharge
6) STEMI6) STEMI
 Thrombolytic medication within 30 minutesThrombolytic medication within 30 minutes
 PCI within 120 minutesPCI within 120 minutes
7) Counseling smoking cessation7) Counseling smoking cessation
8) Cardiac rehab referral8) Cardiac rehab referral
What is the Most CommonWhat is the Most Common
Readmission Diagnosis?Readmission Diagnosis?
Background
• ACE-Inhibitors or angiotensin receptor blockers (ARBs) and
beta blockers reduce morbidity and mortality in patients with
heart failure (HF) and left ventricular systolic dysfunction
(LVSD).
• The use of evidence-based therapies such as ACE-Inhibitors,
ARBs and beta blockers with HF and LVSD is significantly
lower in patients with increased risk.
• In order to optimize the use of evidence based therapies and
improve HF outcomes, more data is needed to assess how to
safely treat high risk patients with contraindications.
Peterson PN, et al. CIRCULATIONAHA/2009/879478
•18,307 patients with LV systolic dysfunction surviving hospitalization
between January 2005 & June 2007
•From 194 GWTG-HF participating hospitals
•GWTG-HF risk prediction score used
to categorize patients according to their estimated in-hospital mortality risk
Most Under-PrescribedMost Under-Prescribed
(or “forgotten”)(or “forgotten”)
Cardiac Meds onCardiac Meds on
Hospital Discharge??Hospital Discharge??
1990’s – Era of “Stent Mania”1990’s – Era of “Stent Mania”
JF
How long do Patients needHow long do Patients need
to take ASA & Plavix/Effientto take ASA & Plavix/Effient
after receiving a coronaryafter receiving a coronary
stent?stent?
 7,402 patients S/P DES did not fill7,402 patients S/P DES did not fill
clopidogrel prescription on day ofclopidogrel prescription on day of
dischargedischarge
 Median time delay 3 days (range 1-23Median time delay 3 days (range 1-23
days)days)
 1 in 6 patients delay filling clopidogrel1 in 6 patients delay filling clopidogrel
prescriptionprescription
Circ Cardiovasc Qual Outcomes 2010;3 261-266
Patients with any delay in filling prescription had
Higher death/MI rates (14% versus 7.9% P<0.001)
Now Let’s Throw CoumadinNow Let’s Throw Coumadin
into the Mix…..into the Mix…..
 What to do with the patient on CoumadinWhat to do with the patient on Coumadin
who gets a stent?who gets a stent?
 Aspirin doseAspirin dose
 Risk of BleedingRisk of Bleeding
 Dietary restrictionsDietary restrictions
Can I eat
Salad and
Green Vegetables?
How many people areHow many people are
ACTIVELY involved inACTIVELY involved in
Hospital Discharging?Hospital Discharging?
Adverse Events after Discharge
 Telephone interviews with 400 patients
 76 (19%) had adverse events
 23 of these judged preventable
“The most common deficit in the provision of
discharge care was poor communication
between the hospital caregivers and either
the patient or the primary care physician.”
Ann Intern Med 2003;138:161-7.
30-Day Hospital Re-Admit Rate30-Day Hospital Re-Admit Rate
Patients with identified medPatients with identified med
discrepanciesdiscrepancies
14.3%14.3%
Patients withPatients with nono identified medidentified med
discrepanciesdiscrepancies
6.1%6.1%
P=0.041
Medication reconciliation
ensures that patients receive
all intended medications and
no unintended medications
following transitions in care
locations.

More Related Content

What's hot

Edoxaban versus warfarin in patients with atrial fibrallation
Edoxaban versus warfarin in patients with atrial fibrallationEdoxaban versus warfarin in patients with atrial fibrallation
Edoxaban versus warfarin in patients with atrial fibrallation
DrJawad Butt
 
Pepe R. Nuovi Anticoagulanti. ASMaD 2013
Pepe R. Nuovi Anticoagulanti. ASMaD 2013Pepe R. Nuovi Anticoagulanti. ASMaD 2013
Pepe R. Nuovi Anticoagulanti. ASMaD 2013
Gianfranco Tammaro
 
Strive Teleconf Presentation Dec6 2006
Strive Teleconf Presentation Dec6 2006Strive Teleconf Presentation Dec6 2006
Strive Teleconf Presentation Dec6 2006
MedicineAndHealthCancer
 
Journal_Club_March_2016
Journal_Club_March_2016Journal_Club_March_2016
Journal_Club_March_2016
Thu Nguyen
 
MAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & ResultsMAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & Results
theheart.org
 
Does it matter how congestion is relieved
Does it matter how congestion is relievedDoes it matter how congestion is relieved
Does it matter how congestion is relieved
drucsamal
 
Anticoagulation in pci
Anticoagulation in pciAnticoagulation in pci
Anticoagulation in pci
cardiositeindia
 
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017
Steve Mathieu
 
Breaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuumBreaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuum
KadarabadNarsingarao
 
THE ENGAGE AF TIMI 48 trial
THE ENGAGE AF TIMI 48 trialTHE ENGAGE AF TIMI 48 trial
THE ENGAGE AF TIMI 48 trial
Praveen Nagula
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acs
cardiositeindia
 
Engage af timi 48 - lawrie
Engage af timi 48 - lawrieEngage af timi 48 - lawrie
Engage af timi 48 - lawrie
Faraz Lawrie
 
Anti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agentsAnti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agents
Ashraf Reda
 
Novedades en el manejo de la Insuficiencia Cardiaca Crónica
Novedades en el manejo de la Insuficiencia Cardiaca CrónicaNovedades en el manejo de la Insuficiencia Cardiaca Crónica
Novedades en el manejo de la Insuficiencia Cardiaca Crónica
Sociedad Española de Cardiología
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
Praveen Nagula
 
ICU Trials summary
ICU Trials summaryICU Trials summary
ICU Trials summary
Sherif Elbadrawy
 
management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...
Muraja
 
New Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS TreatmentNew Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS Treatment
PERKI Pekanbaru
 
How to Use Cangrelor - Dr. Geisler
How to Use Cangrelor - Dr. GeislerHow to Use Cangrelor - Dr. Geisler
How to Use Cangrelor - Dr. Geisler
Sociedad Española de Cardiología
 
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervationPancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
International Chair on Interventional Cardiology and Transradial Approach
 

What's hot (20)

Edoxaban versus warfarin in patients with atrial fibrallation
Edoxaban versus warfarin in patients with atrial fibrallationEdoxaban versus warfarin in patients with atrial fibrallation
Edoxaban versus warfarin in patients with atrial fibrallation
 
Pepe R. Nuovi Anticoagulanti. ASMaD 2013
Pepe R. Nuovi Anticoagulanti. ASMaD 2013Pepe R. Nuovi Anticoagulanti. ASMaD 2013
Pepe R. Nuovi Anticoagulanti. ASMaD 2013
 
Strive Teleconf Presentation Dec6 2006
Strive Teleconf Presentation Dec6 2006Strive Teleconf Presentation Dec6 2006
Strive Teleconf Presentation Dec6 2006
 
Journal_Club_March_2016
Journal_Club_March_2016Journal_Club_March_2016
Journal_Club_March_2016
 
MAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & ResultsMAGELLAN trial - Summary & Results
MAGELLAN trial - Summary & Results
 
Does it matter how congestion is relieved
Does it matter how congestion is relievedDoes it matter how congestion is relieved
Does it matter how congestion is relieved
 
Anticoagulation in pci
Anticoagulation in pciAnticoagulation in pci
Anticoagulation in pci
 
Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017Hot Topics in Critical Care - March 2017
Hot Topics in Critical Care - March 2017
 
Breaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuumBreaking the-cardiovascular-disease-continuum
Breaking the-cardiovascular-disease-continuum
 
THE ENGAGE AF TIMI 48 trial
THE ENGAGE AF TIMI 48 trialTHE ENGAGE AF TIMI 48 trial
THE ENGAGE AF TIMI 48 trial
 
Choosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acsChoosing antiplatelet therapy before during and after hosp for acs
Choosing antiplatelet therapy before during and after hosp for acs
 
Engage af timi 48 - lawrie
Engage af timi 48 - lawrieEngage af timi 48 - lawrie
Engage af timi 48 - lawrie
 
Anti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agentsAnti-platlets from clopidogrel to the new agents
Anti-platlets from clopidogrel to the new agents
 
Novedades en el manejo de la Insuficiencia Cardiaca Crónica
Novedades en el manejo de la Insuficiencia Cardiaca CrónicaNovedades en el manejo de la Insuficiencia Cardiaca Crónica
Novedades en el manejo de la Insuficiencia Cardiaca Crónica
 
Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates Management strategy in HF with ARNI - Recent updates
Management strategy in HF with ARNI - Recent updates
 
ICU Trials summary
ICU Trials summaryICU Trials summary
ICU Trials summary
 
management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...management of patients on oral anticoagulants & antiplatelet therapy requirin...
management of patients on oral anticoagulants & antiplatelet therapy requirin...
 
New Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS TreatmentNew Option of Antiplatelet and Controversies in ACS Treatment
New Option of Antiplatelet and Controversies in ACS Treatment
 
How to Use Cangrelor - Dr. Geisler
How to Use Cangrelor - Dr. GeislerHow to Use Cangrelor - Dr. Geisler
How to Use Cangrelor - Dr. Geisler
 
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervationPancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
Pancholy SB - AIMRADIAL 2014 Endovascular - Renal denervation
 

Similar to Pharmacy lecture: Hospital Discharge Pitfalls

Cain dex peds board review
Cain dex peds board reviewCain dex peds board review
Cain dex peds board review
James Cain
 
Pharmaceutical care plan
Pharmaceutical care planPharmaceutical care plan
Pharmaceutical care plan
Norliza Ariffin
 
PHYSIOLOGICAL INTEGRITY Risk.pdf
PHYSIOLOGICAL INTEGRITY Risk.pdfPHYSIOLOGICAL INTEGRITY Risk.pdf
PHYSIOLOGICAL INTEGRITY Risk.pdf
HaroldSuarez10
 
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Indian dental academy
 
General care of the surgical patient
General care of the surgical patient  General care of the surgical patient
General care of the surgical patient
DrDivya Naveen
 
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMADISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
AlyciaGold776
 
Afib guidelines
Afib guidelinesAfib guidelines
Afib guidelines
DR RML DELHI
 
Evidence-Based Medicine Overview
Evidence-Based Medicine OverviewEvidence-Based Medicine Overview
Evidence-Based Medicine Overview
Dr. Faisal Al Haddad
 
St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis Program
SCBHealth
 
Ebm kuliah
Ebm kuliahEbm kuliah
Ebm kuliah
yunilayossiep
 
General Preoperative &Postoperative Care of Surgical Patients
General Preoperative &Postoperative Care of Surgical PatientsGeneral Preoperative &Postoperative Care of Surgical Patients
General Preoperative &Postoperative Care of Surgical Patients
OmarAlaidaroos3
 
Preoperative preparation of the patient
Preoperative preparation of the patientPreoperative preparation of the patient
Preoperative preparation of the patient
Ayman Arafa
 
Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)
Dniz Mejillitaz
 
Decreasing risks of conscious sedation (7 12-14)
Decreasing risks of conscious sedation (7 12-14)Decreasing risks of conscious sedation (7 12-14)
Decreasing risks of conscious sedation (7 12-14)
wgalal1971
 
Importance of taking medical history prior to implant placement/ dental crown...
Importance of taking medical history prior to implant placement/ dental crown...Importance of taking medical history prior to implant placement/ dental crown...
Importance of taking medical history prior to implant placement/ dental crown...
Indian dental academy
 
Copy preoperative preparation
Copy preoperative preparationCopy preoperative preparation
Copy preoperative preparation
Ayman Arafa
 
V07 no1 2dec2017
V07 no1 2dec2017V07 no1 2dec2017
V07 no1 2dec2017
Khondokar Hashibul Islam
 
Copia (2) de 03 pneumonia guidelines-masterton
Copia (2) de 03 pneumonia guidelines-mastertonCopia (2) de 03 pneumonia guidelines-masterton
Copia (2) de 03 pneumonia guidelines-masterton
Carlos Alberto Trapani
 
Preoperative evaluation
Preoperative evaluationPreoperative evaluation
Preoperative evaluation
Kerolus Shehata
 
betablocker post MI clinical trial , for herat faliure with presered EF
betablocker post MI clinical trial , for herat faliure with presered EFbetablocker post MI clinical trial , for herat faliure with presered EF
betablocker post MI clinical trial , for herat faliure with presered EF
emergencyislamic
 

Similar to Pharmacy lecture: Hospital Discharge Pitfalls (20)

Cain dex peds board review
Cain dex peds board reviewCain dex peds board review
Cain dex peds board review
 
Pharmaceutical care plan
Pharmaceutical care planPharmaceutical care plan
Pharmaceutical care plan
 
PHYSIOLOGICAL INTEGRITY Risk.pdf
PHYSIOLOGICAL INTEGRITY Risk.pdfPHYSIOLOGICAL INTEGRITY Risk.pdf
PHYSIOLOGICAL INTEGRITY Risk.pdf
 
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
Dental Implant 1 /certified fixed orthodontic courses by Indian dental academy
 
General care of the surgical patient
General care of the surgical patient  General care of the surgical patient
General care of the surgical patient
 
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMADISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
DISCHARGE SUMMARY PCI IN THE ELDERLY PATIENT1DISCHARGE SUMMA
 
Afib guidelines
Afib guidelinesAfib guidelines
Afib guidelines
 
Evidence-Based Medicine Overview
Evidence-Based Medicine OverviewEvidence-Based Medicine Overview
Evidence-Based Medicine Overview
 
St. David's Prophylaxis Program
St. David's Prophylaxis ProgramSt. David's Prophylaxis Program
St. David's Prophylaxis Program
 
Ebm kuliah
Ebm kuliahEbm kuliah
Ebm kuliah
 
General Preoperative &Postoperative Care of Surgical Patients
General Preoperative &Postoperative Care of Surgical PatientsGeneral Preoperative &Postoperative Care of Surgical Patients
General Preoperative &Postoperative Care of Surgical Patients
 
Preoperative preparation of the patient
Preoperative preparation of the patientPreoperative preparation of the patient
Preoperative preparation of the patient
 
Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)Nejmoa1507688 (1) (1)
Nejmoa1507688 (1) (1)
 
Decreasing risks of conscious sedation (7 12-14)
Decreasing risks of conscious sedation (7 12-14)Decreasing risks of conscious sedation (7 12-14)
Decreasing risks of conscious sedation (7 12-14)
 
Importance of taking medical history prior to implant placement/ dental crown...
Importance of taking medical history prior to implant placement/ dental crown...Importance of taking medical history prior to implant placement/ dental crown...
Importance of taking medical history prior to implant placement/ dental crown...
 
Copy preoperative preparation
Copy preoperative preparationCopy preoperative preparation
Copy preoperative preparation
 
V07 no1 2dec2017
V07 no1 2dec2017V07 no1 2dec2017
V07 no1 2dec2017
 
Copia (2) de 03 pneumonia guidelines-masterton
Copia (2) de 03 pneumonia guidelines-mastertonCopia (2) de 03 pneumonia guidelines-masterton
Copia (2) de 03 pneumonia guidelines-masterton
 
Preoperative evaluation
Preoperative evaluationPreoperative evaluation
Preoperative evaluation
 
betablocker post MI clinical trial , for herat faliure with presered EF
betablocker post MI clinical trial , for herat faliure with presered EFbetablocker post MI clinical trial , for herat faliure with presered EF
betablocker post MI clinical trial , for herat faliure with presered EF
 

Recently uploaded

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
rightmanforbloodline
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
70KRISHPATEL
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
TEST BANK For An Introduction to Brain and Behavior, 7th Edition by Bryan Kol...
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
THERAPEUTIC ANTISENSE MOLECULES .pptx
THERAPEUTIC ANTISENSE MOLECULES    .pptxTHERAPEUTIC ANTISENSE MOLECULES    .pptx
THERAPEUTIC ANTISENSE MOLECULES .pptx
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 

Pharmacy lecture: Hospital Discharge Pitfalls

  • 1. Pitfalls During HospitalPitfalls During Hospital Discharges:Discharges: Focus on CardiologyFocus on Cardiology Presented by:Presented by: Carolyn StrimikeCarolyn Strimike Cardiology Nurse PractitionerCardiology Nurse Practitioner
  • 2. Components of HospitalComponents of Hospital Discharge InstructionsDischarge Instructions::  Activity restrictions/guidelinesActivity restrictions/guidelines  Risk Factor ModificationRisk Factor Modification  Dietary restrictionsDietary restrictions  Home care/monitoring (dressings, BP, bloodHome care/monitoring (dressings, BP, blood sugar, weights)sugar, weights)  Physician Follow-up (routine, problems –Physician Follow-up (routine, problems – who and when to contact)who and when to contact)  Follow-up testingFollow-up testing  Medications (existing and new)Medications (existing and new)
  • 3. How much time do you thinkHow much time do you think a Physician should spenda Physician should spend providing Dischargeproviding Discharge Instructions?Instructions?
  • 4. What is Average AmountWhat is Average Amount of Time MD spendsof Time MD spends on Dischargeon Discharge Instructions?Instructions?
  • 5. Most Common QuestionMost Common Question Patients Ask UponPatients Ask Upon Discharge?Discharge? “When can I Leave?”
  • 6. Rates of CMS Rehospitalization WithinRates of CMS Rehospitalization Within 30 Days after Hospital Discharge30 Days after Hospital Discharge Jencks SF et al.Jencks SF et al. N Engl J MedN Engl J Med 2009;360:1418-14282009;360:1418-1428
  • 7. ED Visits Post DischargeED Visits Post Discharge  2.3 million visits from patients2.3 million visits from patients discharged from hospital within 7 daysdischarged from hospital within 7 days  Uninsured 3 times more likely to visitUninsured 3 times more likely to visit EDED
  • 8. 1/3 chronically ill adults do not use1/3 chronically ill adults do not use medications due to cost and do not tellmedications due to cost and do not tell cliniciansclinicians Arch Int Med 2004 (164) 1749-55Arch Int Med 2004 (164) 1749-55
  • 9. MedicationMedication Noncompliance orNoncompliance or Mistakes Account forMistakes Account for 24% of Readmission Rate24% of Readmission Rate  Multidrugs/ multinames: “You meanMultidrugs/ multinames: “You mean WarfarinWarfarin andand CoumadinCoumadin are the same drug?”are the same drug?”  Use both generic and brands whenever possibleUse both generic and brands whenever possible when teaching ptswhen teaching pts  Discharge medication lists need to be explicitDischarge medication lists need to be explicit  Check on patient’s system for taking medicationsCheck on patient’s system for taking medications  Seven day/ 4 compartment per day pill boxes are helpfulSeven day/ 4 compartment per day pill boxes are helpful  A home visit or f/u phone call is VERY helpfulA home visit or f/u phone call is VERY helpful
  • 10.  70% Patients Use Alternative Therapy70% Patients Use Alternative Therapy  50 to 70% patients do NOT report50 to 70% patients do NOT report herbal medication usage – MUST ASKherbal medication usage – MUST ASK PATIENTSPATIENTS
  • 11.
  • 12.  AntiplateletsAntiplatelets  Beta-BlockersBeta-Blockers  ACEI/ARBsACEI/ARBs  StatinsStatins  CoumadinCoumadin
  • 13. Acute MI Quality MeasuresAcute MI Quality Measures 1) Aspirin at arrival1) Aspirin at arrival 2)2) Aspirin at dischargeAspirin at discharge 3)3) ACE inhibitor or ARB for LV systolicACE inhibitor or ARB for LV systolic dysfunctiondysfunction 4) Beta-blockers at arrival4) Beta-blockers at arrival 5)5) Beta-blockers at dischargeBeta-blockers at discharge 6) STEMI6) STEMI  Thrombolytic medication within 30 minutesThrombolytic medication within 30 minutes  PCI within 120 minutesPCI within 120 minutes 7) Counseling smoking cessation7) Counseling smoking cessation 8) Cardiac rehab referral8) Cardiac rehab referral
  • 14. What is the Most CommonWhat is the Most Common Readmission Diagnosis?Readmission Diagnosis?
  • 15. Background • ACE-Inhibitors or angiotensin receptor blockers (ARBs) and beta blockers reduce morbidity and mortality in patients with heart failure (HF) and left ventricular systolic dysfunction (LVSD). • The use of evidence-based therapies such as ACE-Inhibitors, ARBs and beta blockers with HF and LVSD is significantly lower in patients with increased risk. • In order to optimize the use of evidence based therapies and improve HF outcomes, more data is needed to assess how to safely treat high risk patients with contraindications. Peterson PN, et al. CIRCULATIONAHA/2009/879478 •18,307 patients with LV systolic dysfunction surviving hospitalization between January 2005 & June 2007 •From 194 GWTG-HF participating hospitals •GWTG-HF risk prediction score used to categorize patients according to their estimated in-hospital mortality risk
  • 16.
  • 17.
  • 18. Most Under-PrescribedMost Under-Prescribed (or “forgotten”)(or “forgotten”) Cardiac Meds onCardiac Meds on Hospital Discharge??Hospital Discharge??
  • 19. 1990’s – Era of “Stent Mania”1990’s – Era of “Stent Mania”
  • 20.
  • 21. JF
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28. How long do Patients needHow long do Patients need to take ASA & Plavix/Effientto take ASA & Plavix/Effient after receiving a coronaryafter receiving a coronary stent?stent?
  • 29.  7,402 patients S/P DES did not fill7,402 patients S/P DES did not fill clopidogrel prescription on day ofclopidogrel prescription on day of dischargedischarge  Median time delay 3 days (range 1-23Median time delay 3 days (range 1-23 days)days)  1 in 6 patients delay filling clopidogrel1 in 6 patients delay filling clopidogrel prescriptionprescription Circ Cardiovasc Qual Outcomes 2010;3 261-266
  • 30. Patients with any delay in filling prescription had Higher death/MI rates (14% versus 7.9% P<0.001)
  • 31. Now Let’s Throw CoumadinNow Let’s Throw Coumadin into the Mix…..into the Mix…..  What to do with the patient on CoumadinWhat to do with the patient on Coumadin who gets a stent?who gets a stent?  Aspirin doseAspirin dose  Risk of BleedingRisk of Bleeding  Dietary restrictionsDietary restrictions Can I eat Salad and Green Vegetables?
  • 32. How many people areHow many people are ACTIVELY involved inACTIVELY involved in Hospital Discharging?Hospital Discharging?
  • 33. Adverse Events after Discharge  Telephone interviews with 400 patients  76 (19%) had adverse events  23 of these judged preventable “The most common deficit in the provision of discharge care was poor communication between the hospital caregivers and either the patient or the primary care physician.” Ann Intern Med 2003;138:161-7.
  • 34. 30-Day Hospital Re-Admit Rate30-Day Hospital Re-Admit Rate Patients with identified medPatients with identified med discrepanciesdiscrepancies 14.3%14.3% Patients withPatients with nono identified medidentified med discrepanciesdiscrepancies 6.1%6.1% P=0.041
  • 35. Medication reconciliation ensures that patients receive all intended medications and no unintended medications following transitions in care locations.